US OptionsDetailed Quotes
MRK240830C113000
- 4.85
- -0.30-5.83%
15min DelayClose Aug 30 16:00 ET
4.85High4.80Low
4.80Open5.15Pre Close34 Volume127 Open Interest113.00Strike Price16.41KTurnover7070.30%IV-0.51%PremiumAug 30, 2024Expiry Date5.45Intrinsic Value100Multiplier-1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.8565Delta0.0405Gamma21.15Leverage Ratio-3892.7302Theta0.0000Rho18.12Eff Leverage0.0002Vega
Merck & Co Stock Discussion
Sign in to post a comment
🚀 Buckle up for upcoming PDUFAs in September! 👇
$Travere Therapeutic (TVTX.US)$ : FILSPARI (Sparsentan)
$Avadel Pharmaceuticals (AVDL.US)$ : LUMRYZ (FT218)
$Iterum Therapeutics (ITRM.US)$ : Sulopenem - AdCom 🗓️
$Sanofi (SNY.US)$ & $Regeneron Pharmaceuticals (REGN.US)$ : Dupixent
$Vanda Pharmaceuticals (VNDA.US)$ : Tradipitant
$Zevra Therapeutics (ZVRA.US)$ : Arimoclomol
$Heron Therapeutics (HRTX.US)$ : ZYNRELEF® Vial Access Needle
$Merck & Co (MRK.US)$ : KEYTRUDA+ chemotherapy
$Bristol-Myers Squibb (BMY.US)$ : KarXT (...
$Travere Therapeutic (TVTX.US)$ : FILSPARI (Sparsentan)
$Avadel Pharmaceuticals (AVDL.US)$ : LUMRYZ (FT218)
$Iterum Therapeutics (ITRM.US)$ : Sulopenem - AdCom 🗓️
$Sanofi (SNY.US)$ & $Regeneron Pharmaceuticals (REGN.US)$ : Dupixent
$Vanda Pharmaceuticals (VNDA.US)$ : Tradipitant
$Zevra Therapeutics (ZVRA.US)$ : Arimoclomol
$Heron Therapeutics (HRTX.US)$ : ZYNRELEF® Vial Access Needle
$Merck & Co (MRK.US)$ : KEYTRUDA+ chemotherapy
$Bristol-Myers Squibb (BMY.US)$ : KarXT (...
7
4
$Merck & Co (MRK.US)$ let's close the gap this week
1
🚨 This Week’s PDUFAs:
$Regeneron Pharmaceuticals (REGN.US)$ : 🤔
⇨ Linvoseltamab
‣ Multiple myeloma
‣ PDUFA: 8/22/24 (BLA)
🗓️ Last Week’s PDUFAs:
$Gilead Sciences (GILD.US)$ : Approved 8/14 🎉
⇨ Livdelzi (Seladelpar)
‣ Primary biliary cholangitis (PBC)
‣ PDUFA: 8/14/24 (NDA)
$Ascendis Pharma A/S (ASND.US)$ : Approved 8/12 🎉
⇨ YORVIPATH (palopegteriparatide)
‣ Hypoparathyroidism
‣ PDUFA: 8/14/24 (NDA)
$Syndax Pharmaceuticals (SNDX.US)$ & $Incyte (INCY.US)$ : Approved 8/14 🎉
⇨ Nikt...
$Regeneron Pharmaceuticals (REGN.US)$ : 🤔
⇨ Linvoseltamab
‣ Multiple myeloma
‣ PDUFA: 8/22/24 (BLA)
🗓️ Last Week’s PDUFAs:
$Gilead Sciences (GILD.US)$ : Approved 8/14 🎉
⇨ Livdelzi (Seladelpar)
‣ Primary biliary cholangitis (PBC)
‣ PDUFA: 8/14/24 (NDA)
$Ascendis Pharma A/S (ASND.US)$ : Approved 8/12 🎉
⇨ YORVIPATH (palopegteriparatide)
‣ Hypoparathyroidism
‣ PDUFA: 8/14/24 (NDA)
$Syndax Pharmaceuticals (SNDX.US)$ & $Incyte (INCY.US)$ : Approved 8/14 🎉
⇨ Nikt...
7
$Teladoc Health (TDOC.US)$ : “What’s going on there, right now we’ve got this Cathie wood, she sells the stock almost every day. She bought it much higher, it’s really painful to watch.”
$Fortinet (FTNT.US)$ : “Fortinet reported a very good quarter...I remain committed to Nikesh Arora and Palo Alto Networks, which I think is doing the best of all of them.”
$Enova (ENVA.US)$ : “Enova, a little dicey. A little dicey because it’s untraditional lending...
$Fortinet (FTNT.US)$ : “Fortinet reported a very good quarter...I remain committed to Nikesh Arora and Palo Alto Networks, which I think is doing the best of all of them.”
$Enova (ENVA.US)$ : “Enova, a little dicey. A little dicey because it’s untraditional lending...
1
$Merck & Co (MRK.US)$ Keytruda showing good growth, eps and revenue beat, eps forecast cut abit already crash
Good afternoon, traders. Happy Tuesday, the market is open and indexes are mixed. Today is a major earnigns relase day, with $Microsoft (MSFT.US)$ and $Advanced Micro Devices (AMD.US)$ posting results after the bell - check it out on moomoo live.
My name is Kevin Travers; here are stories from the herd on Wall St today.
$CrowdStrike (CRWD.US)$ fell 9%, the lowest on the S&P 500. The stock began moving lower late Monday followi...
My name is Kevin Travers; here are stories from the herd on Wall St today.
$CrowdStrike (CRWD.US)$ fell 9%, the lowest on the S&P 500. The stock began moving lower late Monday followi...
42
3
No comment yet
RDK79 : Sorry, what’s a pdufa?
Xyno RDK79 : Prescription Drug User Fee Act, means FDA approval or rejection for a drug to go to market. One of the most important events to monitor if you are into pharma companies stock.
RDK79 Xyno : Thank you!
Tonyco : What site is that?